RxDoctor Payments DataLook up a doctor →

Sunto Yen, MD

Physical Medicine and Rehabilitation · Hillside, ILNPI 1255610937

Payments from drug & device makers

$7,340in general payments, 2019–2025

Across 455 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$963
  • Amarin Pharma, Inc.$816
  • Novartis$656
  • Novo Nordisk$574
  • Merck$410
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$7,29799%
  • Education$431%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,340 in reported general payments places this provider in the 95th percentile of 433 physical medicine and rehabilitation providers in Illinois.

See all physical medicine and rehabilitation providers in Illinois

Medicare billing

Part B allowed, 2024
$590,400
Medicare patients
406
Services billed
17,233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide22$75,990
EliquisApixaban66$43,210
Nurtec OdtRimegepant Sulfate19$39,394
OzempicSemaglutide29$33,262
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$28,040
RybelsusSemaglutide19$26,384
JanuviaSitagliptin Phosphate31$26,086
EntrestoSacubitril/Valsartan19$23,566
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen756$22,984
FarxigaDapagliflozin Propanediol21$22,900
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$22,296
TrulicityDulaglutide19$19,221
Lidocaine124$13,195
MovantikNaloxegol Oxalate18$10,625
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$251$82,60585 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$963$75,99022 claims
Novo NordiskOzempic, Rybelsus$574$59,64748 claims
AstraZenecaBreztri Aerosphere, Farxiga$1,359$50,94155 claims
GSKTrelegy Ellipta, Anoro Ellipta$203$27,54938 claims
MerckJanuvia$410$26,08631 claims
NovartisEntresto$656$23,56619 claims
Redhill Biopharma Inc.Movantik$135$10,62518 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$35$3,99355 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 433 physical medicine and rehabilitation providers in Illinois.

Other physical medicine and rehabilitation in Hillside

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →